100 related articles for article (PubMed ID: 2023630)
1. Muscle damage in mdx mice.
Jackson MJ; McArdle A; Edwards RH; Jones DA
Nature; 1991 Apr; 350(6320):664. PubMed ID: 2023630
[No Abstract] [Full Text] [Related]
2. The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy.
Danko I; Chapman V; Wolff JA
Pediatr Res; 1992 Jul; 32(1):128-31. PubMed ID: 1635838
[TBL] [Abstract][Full Text] [Related]
3. Increasing the proliferative capacity of muscular dystrophy myoblasts.
Yang J; Seelig M; Rayner S; Bredesen DE
Muscle Nerve; 1992 Aug; 15(8):941-8. PubMed ID: 1495511
[TBL] [Abstract][Full Text] [Related]
4. Breeding of the gad-mdx mouse: influence of genetically induced denervation on dystrophic muscle fibers.
Suh JG; Yamazaki A; Tomita T
Lab Anim Sci; 1994 Feb; 44(1):42-6. PubMed ID: 8007658
[TBL] [Abstract][Full Text] [Related]
5. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
[TBL] [Abstract][Full Text] [Related]
6. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
Montgomery E; Pennington C; Isales CM; Hamrick MW
Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
[TBL] [Abstract][Full Text] [Related]
7. Comparison of basic fibroblast growth factor in X-linked dystrophin-deficient myopathies of human, dog and mouse.
Anderson JE; Kakulas BA; Jacobsen PF; Johnsen RD; Kornegay JN; Grounds MD
Growth Factors; 1993; 9(2):107-21. PubMed ID: 8217214
[TBL] [Abstract][Full Text] [Related]
8. Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy.
Araki E; Nakamura K; Nakao K; Kameya S; Kobayashi O; Nonaka I; Kobayashi T; Katsuki M
Biochem Biophys Res Commun; 1997 Sep; 238(2):492-7. PubMed ID: 9299538
[TBL] [Abstract][Full Text] [Related]
9. Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity.
Spencer MJ; Walsh CM; Dorshkind KA; Rodriguez EM; Tidball JG
J Clin Invest; 1997 Jun; 99(11):2745-51. PubMed ID: 9169505
[TBL] [Abstract][Full Text] [Related]
10. Enhanced sensitivity of mdx mice to intramuscular injection of compound 48/80.
Granchelli JA; Hudecki MS; Pollina CM
Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):351-62. PubMed ID: 7938907
[TBL] [Abstract][Full Text] [Related]
11. Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy.
Karpati G; Carpenter S; Prescott S
Muscle Nerve; 1988 Aug; 11(8):795-803. PubMed ID: 3173406
[TBL] [Abstract][Full Text] [Related]
12. New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin.
Cox GA; Phelps SF; Chapman VM; Chamberlain JS
Nat Genet; 1993 May; 4(1):87-93. PubMed ID: 8099842
[TBL] [Abstract][Full Text] [Related]
13. The effects of hyperthyroidism on muscular dystrophy in the mdx mouse: greater dystrophy in cardiac and soleus muscle.
Anderson JE; Liu L; Kardami E
Muscle Nerve; 1994 Jan; 17(1):64-73. PubMed ID: 8264704
[TBL] [Abstract][Full Text] [Related]
14. Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness.
Marques MJ; Ventura Machado R; Minatel E; Santo Neto H
Muscle Nerve; 2008 Jan; 37(1):61-7. PubMed ID: 17724738
[TBL] [Abstract][Full Text] [Related]
15. Regulation of phosphatidylinositol 3-kinase (PI3K)/Akt and nuclear factor-kappa B signaling pathways in dystrophin-deficient skeletal muscle in response to mechanical stretch.
Dogra C; Changotra H; Wergedal JE; Kumar A
J Cell Physiol; 2006 Sep; 208(3):575-85. PubMed ID: 16741926
[TBL] [Abstract][Full Text] [Related]
16. Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions.
Weller B; Karpati G; Carpenter S
J Neurol Sci; 1990 Dec; 100(1-2):9-13. PubMed ID: 2089145
[TBL] [Abstract][Full Text] [Related]
17. Transfer of full-length Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNA.
Liu F; Nishikawa M; Clemens PR; Huang L
Mol Ther; 2001 Jul; 4(1):45-51. PubMed ID: 11472105
[TBL] [Abstract][Full Text] [Related]
18. Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle.
Spencer MJ; Montecino-Rodriguez E; Dorshkind K; Tidball JG
Clin Immunol; 2001 Feb; 98(2):235-43. PubMed ID: 11161980
[TBL] [Abstract][Full Text] [Related]
19. Improvement in survival and muscle function in an mdx/utrn(-/-) double mutant mouse using a human retinal dystrophin transgene.
Gaedigk R; Law DJ; Fitzgerald-Gustafson KM; McNulty SG; Nsumu NN; Modrcin AC; Rinaldi RJ; Pinson D; Fowler SC; Bilgen M; Burns J; Hauschka SD; White RA
Neuromuscul Disord; 2006 Mar; 16(3):192-203. PubMed ID: 16487708
[TBL] [Abstract][Full Text] [Related]
20. Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology.
Alter J; Lou F; Rabinowitz A; Yin H; Rosenfeld J; Wilton SD; Partridge TA; Lu QL
Nat Med; 2006 Feb; 12(2):175-7. PubMed ID: 16444267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
